<DOC>
	<DOCNO>NCT00749398</DOCNO>
	<brief_summary>This national , multi-center , observational , prospective photographic atlas study subject treat infliximab moderate-to-severe psoriasis daily clinic accord local country regulation reimbursement .</brief_summary>
	<brief_title>Photographic Library Moderate Severe Psoriasis Subjects Treated With Infliximab ( Study P05047 )</brief_title>
	<detailed_description>Subjects enter study use non-probability sampling method .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Male female , age &gt; =18 moderatetosevere psoriasis . Patient physician decide initiate psoriasis treatment infliximab accordance term European labeling . Patient must demonstrate his/her willingness participate observational study sign write consent . Patient unable understand answer self administer questionnaire . No specific noninclusion criterion apply eligible patient . Contradiction and/or Precaution list Summary Product Characteristics .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>